Clinical Trials Logo

Sleep Wake Disorders clinical trials

View clinical trials related to Sleep Wake Disorders.

Filter by:

NCT ID: NCT03614377 Active, not recruiting - Sleep Disorder Clinical Trials

DEvice-Detected CArdiac Tachyarrhythmic Events and Sleep-disordered Breathing (DEDiCATES)

DEDiCATES
Start date: April 28, 2017
Phase:
Study type: Observational [Patient Registry]

This prospective multicenter registry study aims to determine whether device-detected sleep-disordered breathing events are associated increased risk of cardiac arrhythmias or other cardiovascular outcomes.

NCT ID: NCT03606707 Recruiting - Sleep Disturbance Clinical Trials

Efficacy of Fluoroscopic Guided Atlantoaxial Joint Injection on Head and Neck Pain and Sleep Quality in RA Patients

Start date: June 1, 2018
Phase: Early Phase 1
Study type: Interventional

Efficacy of intra-articular steroid injection for inflamed atlantoaxial joint in patients with rheumatoid arthritis Inclusion criteria Patients with rheumatoid arthritis with MRI findings of atlantoaxial joint inflammation and failure of resolution after 2 weeks systemic steroid administration Exclusion criteria Coagulopathy, allergy to contrast material, pregnancy Interventional group (AS) group, received intra-articular steroid injection for atlantoaxial joint. , in addition to methotrexate and chloroquine 400 mg per day.

NCT ID: NCT03594851 Completed - Sleep Disorder Clinical Trials

Evaluation of the Benefits of Individualized Advice Administration on Quality of Sleep for the Elderly Living at Home

CISPAD
Start date: January 8, 2018
Phase: N/A
Study type: Interventional

Sleep disorder is often a complaint from the older people. Prevalence of sleep disorder increases with aging and reaches between 20 to 45% of the people of 65 years old and more. Sleep physiologically changes with aging. Sleep can also be disturbed by other factors such as intercurrent or related chronic pathologies, environmental change (institutionalized, death of a spouseā€¦), or some medical treatments. Regardless of interindividual variabilities, normative criteria have been defined by a meta-analysis: insomnia can be diagnosed if night wakings are more than 60min and/or if sleep latency is more than 30 minutes. Various studies have proved the major role of sleep on health and wellbeing. Sleep disorders have an impact on the quality of perception of health and on the quality of life of people and their spouse. According to the French High Health Authority recommendations, sleep diary and validated scales are the tools to use to investigate sleep disorders. Results from previous studies brought us to consider sleep complaint more specifically and adjust to the heterogeneous population of the investigator's hospital with a subjective approach. This work intends to offer a program of individualized advice to older patients with no cognitive impairment, or with a mild or moderate cognitive impairment, who complain about their sleep quality. Patients with a moderate cognitive impairment who have a caregiver at home can also join the study. The main objective of the study is to evaluate the impact of individualized care for sleep disorders on quality of sleep using the Pittsburgh Sleep Quality Index which validity was demonstrated among the elderly.

NCT ID: NCT03576664 Completed - Sleep Clinical Trials

Effects of Sleep Deprivation and Adrenergic Inhibition on Glymphatic Flow in Humans

Start date: August 28, 2018
Phase: Early Phase 1
Study type: Interventional

The project is aimed at identifying how the adrenergic antagonist 'carvedilol' modulates the effects of sleep deprivation in healthy volunteers. The study is a double-blind, randomized, placebo-controlled, cross-over study. Investigators will include 20 healthy volunteers who will undergo three functional magnetic resonance (fMRI) imaging sessions, one at baseline, and two after sleep deprivation (one night without sleep). The two sleep-deprivation scans are performed in a randomized order where subjects receive placebo or carvedilol, in a within-subject, cross-over study design. The following domains will be described: 1) fMRI imaging of cerebrospinal fluid (CSF) pulsations (glymphatic flow) in the human brain, performed by a combination of fMRI protocols that includes structural (T1, T2, diffusion weighted) and functional (multiband/fast imaging, spectroscopy) imaging. 2) fMRI imaging during wakefulness and sleep are determined by simultaneous electroencephalographic (EEG) recordings. 3) The effects of sleep deprivation on the fMRI derived glymphatic flow signal. 4) The effects of the adrenergic antagonist carvedilol on fMRI measurements and sleep intensity. 5) Quantification of cognitive performance before and after a nap in the MRI. Cognitive testing includes: assessments of visual attention, reaction time, paired-associative memory, working memory, emotional recognition and subjective ratings of sleepiness and mood.

NCT ID: NCT03568045 Completed - Clinical trials for Circadian Rhythm Sleep Disorder, Unspecified

Feasibility Pilot of Bright Light in the Intensive Care Unit

Start date: December 3, 2018
Phase: N/A
Study type: Interventional

To evaluate the feasibility of providing daytime bright light in the ICU in a pilot randomized controlled trial.

NCT ID: NCT03556878 Completed - Sleep Disorder Clinical Trials

Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment

Start date: July 20, 2018
Phase: N/A
Study type: Interventional

The goal is to collect pilot data on an adapted version of the Transdiagnostic Sleep and Circadian intervention (TranS-C), referred to as 'Fitted TranS-C'.

NCT ID: NCT03537963 Recruiting - Sleep Disturbance Clinical Trials

Improving Sleep in BMT Survivors

Start date: May 15, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to: To test a new intervention for sleep disturbance among hematopoietic cell transplant survivors. About 60 hematopoietic cell transplant (HCT) survivors will participate in this intervention. Preliminary Steps: To conduct qualitative interviews with patients, caregivers, and clinicians regarding sleep disturbance in hematopoietic cell transplant (HCT) survivors and on preferences for a new mHealth intervention for sleep disturbance. About 30 individuals (10 HCT survivors, 10 caregivers and 5-10 clinicians) will participate in this part of the study.

NCT ID: NCT03535636 Completed - PTSD Clinical Trials

Sleep Impairments in Refugees Diagnosed With PTSD

PSG-PTSD
Start date: April 20, 2018
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to examine sleep architecture in refugees with PTSD. Polysomnography (PSG) will be carried out to study the occurrence of sleep disorders in patients and healthy controls.

NCT ID: NCT03532828 Active, not recruiting - Sleep Disorder Clinical Trials

Interaction Between Body Posture and Nocturnal Sleeping Disorders in Dysgnathic Patients

Start date: April 9, 2018
Phase: N/A
Study type: Interventional

The role of head posture has been demonstrated in patient with dentofacial deformities. However, the relationship between body posture and jaw disorders is unclear. Moreover, patients with obstructive sleep apnea have the same anatomical abnormalities than patients with dentofacial deformities. The aim of this study is to evaluate, firstly, nocturnal sleeping disorders among patients with jaw disorders. Secondly, the investigators aim to evaluate the interaction between body posture, breathing and dentofacial deformities. A polygraphy will be performed on patient with dentofacial deformities before and after correcting jaw surgery. A postural evaluation will be done using EOS imaging system and a force plate

NCT ID: NCT03532269 Completed - Sleep Disorder Clinical Trials

Validation of the Sleep Assessment Algorithm in the Medical Application Nightly

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

The Nightly medical application prototype is a potential, non-invasive class I medical device. The application has the potential to combine both diagnostic and therapeutic procedures for sleep. At home, Nightly measures the user's motion during sleep and then records the sleep pattern from the received data. The obtained data are then used for the diagnosis of sleep disorders (REM and NREM sleep). Using acoustic and visual stimulation, the application has the capability to support the natural process of falling asleep, provide a better night's sleep by minimizing sleep deprivation and nightmares, while awakening the user at the appropriate moment (during light sleep).